Andrea P. Brockway

Andrea P. Brockway

Saul Ewing LLP

Contact  |  View Bio  |  RSS

Latest Posts › Free Speech


Southern District of New York Finds Amarin Pharma, Inc.’s Off-Label Promotion Is Protected Speech; Company Cannot Be Prosecuted...

Pharmaceutical industry and constitutional buffs have been closely watching Amarin Pharma Inc. v. U.S. Food and Drug Administration. The case presented the (not wholly novel) question whether the First Amendment protects...more

10/2/2015 - Amarin Declaratory Relief DOJ False Claims Act (FCA) FDA First Amendment Free Speech Interstate Commerce Misbranding Misleading Statements Off-Label Use Pharmaceutical Industry Preliminary Injunctions Prescription Drugs Qui Tam Whistleblowers

White Collar Watch - February 2013

In This Issue: - New HIPAA “Megarule” Broadens Enforcement - Government Declines to Seek Rehearing of Landmark Off-Label Speech Decision - Seizure of Rothstein Ponzi Assets Highlights Tension Between...more

2/22/2013 - Forfeiture Statutes Free Speech HIPAA Mary Jo White Off-Label Use Petition For Rehearing Ponzi Scheme White Collar Crimes

2 Results
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.